Annual CFI:
-$17.77M-$185.77M(-110.58%)Summary
- As of today, RARE annual cash from investing is -$17.77 million, with the most recent change of -$185.77 million (-110.58%) on December 31, 2024.
- During the last 3 years, RARE annual cash from investing has risen by +$177.60 million (+90.91%).
- RARE annual cash from investing is now -110.58% below its all-time high of $168.00 million, reached on December 31, 2023.
Performance
RARE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$71.17M-$48.72M(-40.63%)Summary
- As of today, RARE quarterly cash from investing is $71.17 million, with the most recent change of -$48.72 million (-40.63%) on June 30, 2025.
- Over the past year, RARE quarterly cash from investing has increased by +$10.61 million (+17.52%).
- RARE quarterly cash from investing is now -40.63% below its all-time high of $119.89 million, reached on March 31, 2025.
Performance
RARE Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$25.30M+$10.61M(+72.25%)Summary
- As of today, RARE TTM cash from investing is $25.30 million, with the most recent change of +$10.61 million (+72.25%) on June 30, 2025.
- Over the past year, RARE TTM cash from investing has dropped by -$86.98 million (-77.47%).
- RARE TTM cash from investing is now -84.94% below its all-time high of $168.00 million, reached on December 31, 2023.
Performance
RARE TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RARE Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -110.6% | +17.5% | -77.5% |
| 3Y3 Years | +90.9% | -10.1% | -63.9% |
| 5Y5 Years | -36.3% | +182.6% | +112.1% |
RARE Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -110.6% | +93.9% | -40.6% | +126.5% | -84.9% | +108.7% |
| 5Y | 5-Year | -110.6% | +93.9% | -40.6% | +126.5% | -84.9% | +108.7% |
| All-Time | All-Time | -110.6% | +93.9% | -40.6% | +126.5% | -84.9% | +108.7% |
RARE Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $71.17M(-40.6%) | $25.30M(+72.2%) |
| Mar 2025 | - | $119.89M(+16.7%) | $14.69M(+236.4%) |
| Dec 2024 | -$17.77M(-110.6%) | $102.73M(+138.3%) | -$10.77M(+95.1%) |
| Sep 2024 | - | -$268.50M(-543.3%) | -$220.52M(-296.4%) |
| Jun 2024 | - | $60.56M(-35.9%) | $112.28M(-25.7%) |
| Mar 2024 | - | $94.44M(+188.2%) | $151.13M(-10.0%) |
| Dec 2023 | $168.00M(+157.6%) | -$107.02M(-266.4%) | $168.00M(+62.4%) |
| Sep 2023 | - | $64.30M(-35.3%) | $103.42M(+184.3%) |
| Jun 2023 | - | $99.42M(-10.7%) | -$122.74M(+14.2%) |
| Mar 2023 | - | $111.30M(+164.9%) | -$142.99M(+51.0%) |
| Dec 2022 | -$291.65M(-49.3%) | -$171.60M(-6.0%) | -$291.65M(-471.9%) |
| Sep 2022 | - | -$161.86M(-304.5%) | -$51.00M(-172.7%) |
| Jun 2022 | - | $79.17M(+311.9%) | $70.10M(+239.3%) |
| Mar 2022 | - | -$37.36M(-154.1%) | -$50.31M(+74.2%) |
| Dec 2021 | -$195.37M(-9.1%) | $69.06M(+269.4%) | -$195.37M(-17.3%) |
| Sep 2021 | - | -$40.76M(+1.2%) | -$166.53M(+24.8%) |
| Jun 2021 | - | -$41.25M(+77.4%) | -$221.53M(+16.9%) |
| Mar 2021 | - | -$182.42M(-286.3%) | -$266.42M(-48.7%) |
| Dec 2020 | -$179.12M(-1273.7%) | $97.90M(+202.2%) | -$179.12M(+14.6%) |
| Sep 2020 | - | -$95.76M(-11.2%) | -$209.76M(-504.8%) |
| Jun 2020 | - | -$86.14M(+9.4%) | -$34.68M(-397.5%) |
| Mar 2020 | - | -$95.13M(-241.4%) | -$6.97M(+46.5%) |
| Dec 2019 | -$13.04M(+60.9%) | $67.27M(-15.2%) | -$13.04M(-93.3%) |
| Sep 2019 | - | $79.31M(+235.8%) | -$6.74M(+90.3%) |
| Jun 2019 | - | -$58.43M(+42.3%) | -$69.85M(-10.0%) |
| Mar 2019 | - | -$101.19M(-237.6%) | -$63.50M(-90.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$33.33M(-160.1%) | $73.56M(+353.9%) | -$33.33M(+33.1%) |
| Sep 2018 | - | $16.20M(+131.1%) | -$49.79M(-37.5%) |
| Jun 2018 | - | -$52.07M(+26.7%) | -$36.20M(-594.6%) |
| Mar 2018 | - | -$71.03M(-224.4%) | -$5.21M(-109.2%) |
| Dec 2017 | $55.48M(-39.1%) | $57.10M(+91.7%) | $56.42M(+647.5%) |
| Sep 2017 | - | $29.79M(+241.3%) | -$10.30M(-175.3%) |
| Jun 2017 | - | -$21.08M(-124.2%) | $13.68M(-76.7%) |
| Mar 2017 | - | -$9.40M(+2.2%) | $58.74M(-34.7%) |
| Dec 2016 | $91.12M(+131.2%) | -$9.62M(-117.9%) | $89.92M(+36.3%) |
| Sep 2016 | - | $53.77M(+124.2%) | $65.97M(+150.2%) |
| Jun 2016 | - | $23.99M(+10.2%) | -$131.51M(+50.7%) |
| Mar 2016 | - | $21.77M(+164.9%) | -$266.51M(+8.8%) |
| Dec 2015 | -$292.35M(-136.8%) | -$33.56M(+76.6%) | -$292.35M(-6.0%) |
| Sep 2015 | - | -$143.72M(-29.5%) | -$275.81M(-89.4%) |
| Jun 2015 | - | -$111.01M(-2630.9%) | -$145.64M(-134.5%) |
| Mar 2015 | - | -$4.07M(+76.1%) | -$62.11M(+49.7%) |
| Dec 2014 | -$123.44M(-158.6%) | -$17.02M(-25.7%) | -$123.44M(-29.5%) |
| Sep 2014 | - | -$13.54M(+50.7%) | -$95.31M(-15.5%) |
| Jun 2014 | - | -$27.48M(+58.0%) | -$82.55M(+15.8%) |
| Mar 2014 | - | -$65.40M(-688.5%) | -$98.03M(-105.4%) |
| Dec 2013 | -$47.73M(-3907.9%) | $11.11M(+1513.9%) | -$47.73M(+19.1%) |
| Sep 2013 | - | -$786.00K(+98.2%) | -$58.97M(-1.1%) |
| Jun 2013 | - | -$42.96M(-184.5%) | -$58.31M(-279.9%) |
| Mar 2013 | - | -$15.10M(>-9900.0%) | -$15.35M(-6138.2%) |
| Dec 2012 | -$1.19M(-28.9%) | -$124.00K(-1.6%) | -$246.00K(-101.6%) |
| Sep 2012 | - | -$122.00K | -$122.00K |
| Dec 2011 | -$924.00K | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual cash from investing?
- What is the all-time high annual cash from investing for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual cash from investing year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly cash from investing year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM cash from investing year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual cash from investing?
The current annual cash from investing of RARE is -$17.77M
What is the all-time high annual cash from investing for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual cash from investing is $168.00M
What is Ultragenyx Pharmaceutical Inc. annual cash from investing year-on-year change?
Over the past year, RARE annual cash from investing has changed by -$185.77M (-110.58%)
What is Ultragenyx Pharmaceutical Inc. quarterly cash from investing?
The current quarterly cash from investing of RARE is $71.17M
What is the all-time high quarterly cash from investing for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly cash from investing is $119.89M
What is Ultragenyx Pharmaceutical Inc. quarterly cash from investing year-on-year change?
Over the past year, RARE quarterly cash from investing has changed by +$10.61M (+17.52%)
What is Ultragenyx Pharmaceutical Inc. TTM cash from investing?
The current TTM cash from investing of RARE is $25.30M
What is the all-time high TTM cash from investing for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM cash from investing is $168.00M
What is Ultragenyx Pharmaceutical Inc. TTM cash from investing year-on-year change?
Over the past year, RARE TTM cash from investing has changed by -$86.98M (-77.47%)